We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Tag: Alzheimer's disease
MedXY News
EnglishTag

Alzheimer's disease

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Unraveling the Gut–Brain Connection: Tau Propagation via the Vagus Nerve in Alzheimer’s Disease
Clinical UpdatesAlzheimer's diseasegut-brain axis

Unraveling the Gut–Brain Connection: Tau Propagation via the Vagus Nerve in Alzheimer’s Disease

By MedXY|Oct 6, 2025

Recent research reveals that pathological tau can propagate from the brain to the colon through the vagal efferent pathway in Alzheimer’s disease, supporting a novel brain-to-gut axis involvement in disease progression and gut functio

FDA Approves Subcutaneous Lecanemab for Maintenance Treatment in Early Alzheimer’s Disease: A Step Toward More Accessible Care
NeurologyAlzheimer's disease
FDA approval

FDA Approves Subcutaneous Lecanemab for Maintenance Treatment in Early Alzheimer’s Disease: A Step Toward More Accessible Care

By MedXY|Oct 6, 2025

The FDA has approved a subcutaneous form of lecanemab for maintenance therapy in early Alzheimer’s, offering similar clinical benefits to IV dosing with improved convenience and safety, potentially transforming patient care delivery.

Therapeutic Potential of 40 Hz Light Stimulation in Alzheimer’s Disease: Mechanisms, Modalities, and Clinical Insights
Clinical UpdatesAlzheimer's diseasegamma entrainment

Therapeutic Potential of 40 Hz Light Stimulation in Alzheimer’s Disease: Mechanisms, Modalities, and Clinical Insights

By MedXY|Aug 27, 2025

This review synthesizes mechanistic, preclinical, and clinical evidence on 40 Hz light stimulation as a novel therapeutic approach to slow Alzheimer’s disease progression, highlighting safety, efficacy, and modality comparisons.

Obicetrapib Shows Promise in Slowing Alzheimer’s Disease Progression Through Lipid Modulation
Clinical UpdatesAlzheimer's diseaseAPOE4

Obicetrapib Shows Promise in Slowing Alzheimer’s Disease Progression Through Lipid Modulation

By MedXY|Oct 3, 2025

Obicetrapib, a CETP inhibitor, significantly slowed Alzheimer’s disease biomarker progression over 12 months and improved p-tau217 levels in APOE4 carriers while also benefiting lipid profiles in cardiovascular disease patients.

Lithium Orotate as a Novel Therapeutic Avenue for Alzheimer’s Disease: Insights from the Latest Nature Study
Clinical UpdatesAlzheimer's diseaselithium

Lithium Orotate as a Novel Therapeutic Avenue for Alzheimer’s Disease: Insights from the Latest Nature Study

By MedXY|Oct 2, 2025

A Nature study links lithium deficiency in the brain to Alzheimer’s onset and shows lithium orotate reverses memory loss in mice, offering new hope for Alzheimer’s therapy.

Advancing Alzheimer’s Risk Prediction: Multi-Ancestry Polygenic Risk Scores in Hispanic Populations
Clinical UpdatesAlzheimer's diseaseHispanic population

Advancing Alzheimer’s Risk Prediction: Multi-Ancestry Polygenic Risk Scores in Hispanic Populations

By MedXY|Oct 1, 2025

Multi-ancestry polygenic risk scores significantly improve Alzheimer’s disease risk prediction in Hispanic populations compared to traditional single-ancestry models and APOE genotyping alone.

Understanding and Managing Alzheimer’s Disease: A Comprehensive Guide
NeurologyAlzheimer's diseaseDementia

Understanding and Managing Alzheimer’s Disease: A Comprehensive Guide

By MedXY|Oct 1, 2025

An in-depth overview of Alzheimer’s disease, covering its causes, symptoms, diagnosis, treatment options, and caregiving strategies.

Elevated Risk of Alzheimer’s Disease and Related Dementias in Transfeminine Adults: Insights from a Large Cohort Study
Clinical UpdatesAlzheimer's diseaseDementia

Elevated Risk of Alzheimer’s Disease and Related Dementias in Transfeminine Adults: Insights from a Large Cohort Study

By MedXY|Oct 1, 2025

Recent data reveal that transfeminine adults experience significantly higher prevalence of Alzheimer’s disease and related dementias compared to matched cisgender peers, independent of gender-affirming hormone therapy, highlighting ur

Legacy of Leaded Gasoline: New Evidence Links Childhood and Adult Exposure to Cognitive Impairment in Older Adults
Medical NewsAlzheimer's diseasecognitive impairment

Legacy of Leaded Gasoline: New Evidence Links Childhood and Adult Exposure to Cognitive Impairment in Older Adults

By MedXY|Sep 30, 2025

Recent studies confirm that both childhood and adult lead exposure, especially from gasoline and industrial sources, are associated with increased risk for cognitive decline and dementia in later life.

Demographic Data Gaps in FDA Authorization of AI-Based Devices for Alzheimer’s Disease and Related Dementias
AIAlzheimer's diseaseartificial intelligence

Demographic Data Gaps in FDA Authorization of AI-Based Devices for Alzheimer’s Disease and Related Dementias

By MedXY|Sep 30, 2025

Limited demographic data transparency in FDA-authorized AI devices for Alzheimer’s may hinder equitable care and generalizability, highlighting a crucial need for improved dataset representativeness and regulatory oversight.

Walking and Dietary Interventions Offer Cognitive Protection in APOE ε4 Carriers: New Evidence from Longitudinal and Multinational Trials
Clinical UpdatesAlzheimer's diseaseAPOE ε4

Walking and Dietary Interventions Offer Cognitive Protection in APOE ε4 Carriers: New Evidence from Longitudinal and Multinational Trials

By MedXY|Sep 30, 2025

Regular walking and lifestyle interventions slow cognitive decline, especially in APOE ε4 carriers at heightened Alzheimer’s risk, with effects pronounced in women. Evidence underscores the value of simple activity and healthy diet for at-r

Lecanemab in Community Practice: Real-World Safety and Efficacy for Early Alzheimer’s Disease
Clinical UpdatesAlzheimer's diseaselecanemab

Lecanemab in Community Practice: Real-World Safety and Efficacy for Early Alzheimer’s Disease

By MedXY|Sep 30, 2025

Community-based data suggest lecanemab is safe and effective for early-stage Alzheimer’s, with manageable ARIA rates and infusion reactions, particularly in ApoE4 noncarriers.

Alzheimer’s Association Releases First Clinical Guidelines for Blood-Based Biomarkers: Implications for Diagnosis and Practice
Clinical UpdatesAlzheimer's diseasebiomarkers

Alzheimer’s Association Releases First Clinical Guidelines for Blood-Based Biomarkers: Implications for Diagnosis and Practice

By MedXY|Sep 30, 2025

New Alzheimer’s Association guidelines endorse blood-based biomarkers as diagnostic adjuncts, not standalone tests, emphasizing rigorous clinical evaluation and high test accuracy.

Prev
4 / 4
1234
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities